# Compliance With Once-Daily Divalproex Extended-Release Tablets (Depakote-ER) Versus Multiple-Daily Dose Valproic Acid Capsules (Depakene) in Epilepsy:

> **NCT00356018** · — · COMPLETED · sponsor: **Orlando Health, Inc.** · enrollment: 5 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **BEHAVIORAL:** Compliance

## Key facts

- **NCT ID:** NCT00356018
- **Lead sponsor:** Orlando Health, Inc.
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** —
- **Final completion:** 2007-05
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2020-03-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00356018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00356018, "Compliance With Once-Daily Divalproex Extended-Release Tablets (Depakote-ER) Versus Multiple-Daily Dose Valproic Acid Capsules (Depakene) in Epilepsy:". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00356018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*